NewsWhore
06-30-2010, 03:20 PM
CEMI ), which develops, manufactures, markets and licenses point-of-care diagnostic tests, has been notified that Bio-Manguinhos, a division of the Oswaldo Cruz Foundation of Brazil ("FIOCRUZ"), has r...
More... (http://story.brazilsun.com/index.php/ct/9/cid/24437442923341f1/id/36506008/)
More... (http://story.brazilsun.com/index.php/ct/9/cid/24437442923341f1/id/36506008/)